Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
12.68
+0.42 (3.43%)
Oct 29, 2025, 12:12 PM EDT - Market open
Burning Rock Biotech Revenue
Burning Rock Biotech had revenue of 148.55M CNY in the quarter ending June 30, 2025, with 9.61% growth. This brings the company's revenue in the last twelve months to 536.30M, up 5.20% year-over-year. In the year 2024, Burning Rock Biotech had annual revenue of 515.82M, down -4.02%.
Revenue (ttm)
536.30M CNY
Revenue Growth
+5.20%
P/S Ratio
1.73
Revenue / Employee
795,700 CNY
Employees
674
Market Cap
136.52M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 515.82M | -21.61M | -4.02% |
| Dec 31, 2023 | 537.44M | -25.80M | -4.58% |
| Dec 31, 2022 | 563.24M | 55.38M | 10.90% |
| Dec 31, 2021 | 507.86M | 77.96M | 18.13% |
| Dec 31, 2020 | 429.90M | 48.23M | 12.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BNR News
- 5 weeks ago - Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - GlobeNewsWire
- 7 weeks ago - Burning Rock Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Burning Rock Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 7 months ago - Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 10 months ago - Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewsWire
- 11 months ago - Burning Rock Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 11 months ago - Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024 - GlobeNewsWire
- 1 year ago - NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - GlobeNewsWire